Oxygerolan (Oxycodone Hydrochloride)

Oxygerolan is an opioid analgesic that acts on the central nervous system to relieve pain. It is indicated for:

• Acute postoperative pain: provides effective relief following surgical procedures.
• Cancer‑related pain: helps manage persistent pain associated with malignant disease.
• Severe chronic non‑cancer pain: used when pain is intense and other treatments have failed.

• Oxycodone Hydrochloride binds to μ‑opioid receptors in the central nervous system, activating these receptors and inhibiting the transmission of nociceptive signals. This receptor activation reduces neuronal excitability and alters pain perception, producing an analgesic effect without directly affecting inflammatory pathways.

Oxygerolan may cause a range of adverse reactions, most of which are dose‑dependent and reversible.

Common Side Effects

• Constipation: reduced gastrointestinal motility.
• Nausea: mild to moderate queasiness.
• Drowsiness: increased sleepiness or sedation.
• Dizziness: light‑headed sensation.
• Dry mouth: reduced salivation.
• Sweating: increased perspiration.

Serious or Rare Side Effects

• Respiratory depression: slowed or shallow breathing.
• Severe hypotension: marked drop in blood pressure.
• Opioid dependence or addiction: potential for misuse.
• Seizures: rare convulsive episodes.
• Anaphylaxis: severe allergic reaction.
• adrenal insufficiency: rare hormonal imbalance.

When prescribing Oxygerolan, clinicians should consider several safety measures:

• Assess pain severity and prior opioid exposure: ensure appropriate indication.
• Evaluate  ".
• Evaluate  \

• Potential ");